StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Research analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Saturday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

RVP stock opened at $0.64 on Friday. The firm has a 50 day moving average of $0.67 and a two-hundred day moving average of $0.89. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34. The company has a market capitalization of $19.16 million, a price-to-earnings ratio of -1.19 and a beta of 1.98. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.